Pharmacoproteomics is the one of the top journals in the field of pharmacoproteomics. The mission of the pharmacoproteomics journal is to provide a forum for publishing new findings on Pharmacogenomics & Pharmacoproteomics. This journal play a key role in providing knowledge to the society and this knowledge is rising by leaps and bounds within no time.
Pharmacoproteomics is a rapidly advancing field in which the techniques of proteomics are applied to develop pharmaceutical agents. However, this branch of study plays a major role in personalized medicine. The word proteomics itself means the study of proteomes, a proteome being the full complement of proteins expressed by an organism or tissue under specified conditions at a specified time. Proteomes are therefore dynamic, and a given human may have a proteome with as many as two million proteins. The use of this full set of proteins to study the effect of disease or drugs can substitute for much more complex assays in pharmacodynamics at a lower cost in time, financial output, and clinical risk.
Pharmacoproteomics is the use of proteomic technologies in drug discovery and development. Along with pharmacogenomics and pharmacogenetics, pharmacoproteomics will play an important role in the development of personalized medicines in several ways. Proteomic technologies are contributing to molecular diagnostics, which is a basis of personalized medicine.